Clinical laboratory International (CLI)
The leading international magazine for Clinical laboratory Equipment for everyone in the in vitro diagnostics field and related disciplines.
https://clinlabint.com/wp-content/uploads/sites/2/2026/10/OGT-SureSeq-scaled.png
1335
2560
panglobal
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png
panglobal2026-10-14 18:13:122026-10-13 18:16:34OGT unveils automated SureSeq NGS library preparation for Hamilton NGS STAR Line
Hormone tests for diagnosis and therapeutic monitoring of growth hormone deficiency and acromegaly
/in Featured Articles, Protein Analysis, Proteomics & Mass Spectrometryby Dr Jacqueline Gosink Growth hormone (GH), insulin like growth factor I (IGF 1) and IGF binding protein 3 (IGFBP 3) are central regulators of growth and metabolism. Measurement of these biomarkers supports the diagnosis of growth disorders such as GH deficiency in children and acromegaly in adults. The analytes also play an important role […]
Urine biomarkers detect sarcopenia
/in Featured Articles, Urine AnalysisSarcopenia has a big impact on health as we age – and it’s not just about the risk of falls. It is estimated to affect 10–16% of the aging population but challenges with diagnosis mean that this is likely to be an underestimate. Current methods of analysing muscle all have limitations associated with them. CLI […]
Pharmacodynamic assessment of MET tyrosine kinase activation in tumour cells could aid personalized cancer treatment
/in Featured Articles, Tumour MarkersAbnormal MET presence and activity are known to drive tumour growth, persistence and spread. However, although some patients respond well to current therapies many do not, which indicates that there are subtleties about the analysis of MET as a biomarker that have not been adequately analysed to date. CLI chatted with Dr Tony Navas (AbbVie, […]
Quantitative tandem mass tag-based proteomics allows biomarker analysis for Duchenne muscular dystrophy disease progression and therapeutic response assessment
/in Featured ArticlesDuchenne muscular dystrophy is a devastating progressive muscle disease that causes loss of ambulation by age 12 and premature death in early thirties. New gene therapy approaches are extending life span, but the physical assessments currently used make disease progression and therapy monitoring challenging, if not impossible. CLI chatted with Professor Yetrib Hathout and Ahmed […]